Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Bupropion and Varenicline for Smoking Cessation
NCT01806779Phase 2Completed
- Sponsor
- Duke University
- Start
- Mar 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupropion in nicotine dependence, sponsored by Duke University. Started Mar 2013; status: completed.
02
Drugs
bupropion
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01806779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01806779.